AstraZeneca (AZN) China President currently under investigation

Leon Wang, Executive Vice President International and AstraZeneca China President, is cooperating with an ongoing investigation by Chinese authorities.

Our China operations continue under the leadership of the current General Manager of AstraZeneca China.

If requested, AstraZeneca (NASDAQ: AZN) will fully cooperate with the investigation.

You May Also Be Interested In

• ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated statistically significant and clinically meaningful improvement in PFS as 1st-line treatment of patients with HER2-mutant advanced non-small ce
• Himax and Waferlock launch palm vein smart lock with on-device AI
• Infleqtion raises Q2 revenue to $13.5M after contract restatement